Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Cantor Fitzgerald
Queensland Health

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072695

« Back to Dashboard

NDA 072695 describes NORTREL 0.5/35-28, which is a drug marketed by Barr and is included in one NDA. It is available from two suppliers. Additional details are available on the NORTREL 0.5/35-28 profile page.

The generic ingredient in NORTREL 0.5/35-28 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.

Summary for 072695

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 072695

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORTREL 0.5/35-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 072695 ANDA Teva Pharmaceuticals USA, Inc. 0555-9008 0555-9008-67 3 POUCH in 1 CARTON (0555-9008-67) > 1 BLISTER PACK in 1 POUCH (0555-9008-79) > 1 KIT in 1 BLISTER PACK
NORTREL 0.5/35-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 072695 ANDA Mayne Pharma Inc. 51862-318 51862-318-03 3 POUCH in 1 CARTON (51862-318-03) > 1 BLISTER PACK in 1 POUCH (51862-318-01) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;0.5MG
Approval Date:Feb 28, 1992TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: